Home > Annual Financials > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY Financial Statement Analysis
[BOM: 532872|NSE : SPARC]

The Revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have increased by 73.98% YoY .
The Earnings Per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY has increased by Negative YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Annual Financial Results
[BOM: 532872|NSE : SPARC]

StandaloneMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹239 Cr₹137 Cr₹253 Cr₹77 Cr₹183 Cr
Expenses ₹453 Cr₹324 Cr₹388 Cr₹387 Cr₹334 Cr
Operating Profit (Excl OI) ₹-214 Cr₹-187 Cr₹-135 Cr₹-310 Cr₹-151 Cr
Other Income ₹11 Cr₹6.85 Cr₹5.41 Cr₹9.76 Cr₹14 Cr
Interest ₹7.64 Cr₹13 Cr₹11 Cr₹2.68 Cr₹0.09 Cr
Depreciation ₹12 Cr₹10 Cr₹11 Cr₹9.48 Cr₹7.55 Cr
Profit Before Tax ₹-223 Cr₹-203 Cr₹-151 Cr₹-312 Cr₹-145 Cr
Profit After Tax ₹-223 Cr₹-203 Cr₹-151 Cr₹-312 Cr₹-145 Cr
Consolidated Net Profit ₹-223 Cr₹-203 Cr₹-151 Cr₹-312 Cr₹-145 Cr
Earnings Per Share (Rs)₹-6.86₹-7.48₹-5.77₹-11.92₹-5.55
PAT Margin (%)-93.22-148.19-59.75-406.70-79.53
ROE(%)-143.720.000.00-225.08-74.72
ROCE(%)-69.44-225.57-254.10-178.95-59.95
Total Debt/Equity(x)0.00-0.37-1.37-3.590.01

Key Financials

Market Cap : ₹ 11,742.0 Cr
Revenue (TTM) : ₹ 106.7 Cr
Net Profit(TTM) : ₹ -363.4 Cr
EPS (TTM) : ₹ -11.2
P/E (TTM) : -

Industry Peers & Returns1W1M1Y
SUN PHARMA ADVANCED RESEARCH COMPANY -3.6% 0.7% 92.3%
SYNGENE INTERNATIONAL -1.6% -10.8% 16.2%
BLS INTERNATIONAL SERVICES 2.7% -7% 126.5%
LATENT VIEW ANALYTICS -7.4% -14.2% 35.7%
QUESS CORP 0.8% -0.4% 39.6%
DELTA CORP -4.2% -11.9% -34.5%
SECURITY AND INTELLIGENCE SERVICES INDIA -1.4% 1% 27.6%
JUST DIAL -6.6% -8.5% 33.5%
TEAMLEASE SERVICES -3.1% -11.1% 16.4%


SUN PHARMA ADVANCED RESEARCH COMPANY Revenues
[BOM: 532872|NSE : SPARC]

Y-o-Y

73.98 %

5 Yr CAGR

6.90 %

Years Revenues % Change
Mar2023 ₹239 Cr
73.98
Mar2022 ₹137 Cr
-45.74
Mar2021 ₹253 Cr
229.31
Mar2020 ₹77 Cr
-58.00
Mar2019 ₹183 Cr -


SUN PHARMA ADVANCED RESEARCH COMPANY Operating Profit
[BOM: 532872|NSE : SPARC]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Profit % Change
Mar2023 ₹-214 Cr
Negative
Mar2022 ₹-187 Cr
Negative
Mar2021 ₹-135 Cr
Negative
Mar2020 ₹-310 Cr
Negative
Mar2019 ₹-151 Cr -

Operating Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Margin% % Change
Mar2023 -89.65%
Negative
Mar2022 -136.07%
Negative
Mar2021 -53.36%
Negative
Mar2020 -403.59%
Negative
Mar2019 -82.73% -

SUN PHARMA ADVANCED RESEARCH COMPANY Profit After Tax
[BOM: 532872|NSE : SPARC]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Profit After Tax % Change
Mar2023 ₹-223 Cr
Negative
Mar2022 ₹-203 Cr
Negative
Mar2021 ₹-151 Cr
Negative
Mar2020 ₹-312 Cr
Negative
Mar2019 ₹-145 Cr -

PAT Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years PAT Margin(%) % Change
Mar2023 -93.22 %
Negative
Mar2022 -148.19 %
Negative
Mar2021 -59.75 %
Negative
Mar2020 -406.7 %
Negative
Mar2019 -79.53 % -

SUN PHARMA ADVANCED RESEARCH COMPANY Earnings Per Share (EPS)
[BOM: 532872|NSE : SPARC]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years EPS % Change
Mar2023 ₹-6.86
Negative
Mar2022 ₹-7.48
Negative
Mar2021 ₹-5.77
Negative
Mar2020 ₹-12
Negative
Mar2019 ₹-5.55 -

SUN PHARMA ADVANCED RESEARCH COMPANY Return on Capital Employed (ROCE)
[BOM: 532872|NSE : SPARC]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years ROCE % Change
Mar2023 -69.44%
Negative
Mar2022 -225.57%
Negative
Mar2021 -254.1%
Negative
Mar2020 -178.95%
Negative
Mar2019 -59.95% -

SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex

Current Share Price : ₹361.9
Current MarketCap: ₹ 11,742.0 Cr
Updated EOD on :Mar 18,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

-3.6%

0.7%

92.3%

SENSEX

-1%

1%

24.9%

SUN PHARMA ADVANCED RESEARCH COMPANY related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE -2.1% -2.4% 59.2%
S&P BSE 500 -2.2% -0.9% 36.5%
S&P BSE ALLCAP -2.3% -1.4% 38%
S&P BSE 400 MIDSMALLCAP -3.8% -4.8% 50.6%
S&P BSE MIDSMALLCAP -3.9% -5.5% 55.7%
NSE Indices1W1M1Y
NIFTY 500 -2.2% -1% 37.3%
NIFTY500 MULTICAP 50:25:25 -2.8% -2.6% 43%
NIFTY MID SMALL400 -4% -5.3% 52.8%
NIFTY SMALLCAP250 -4.3% -7.5% 55.6%

You may also like the below Video Courses


FAQ about SUN PHARMA ADVANCED RESEARCH COMPANY Financials


How the annual revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have changed ?

The Revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have increased by 73.98% YoY .

How the Earnings per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY have changed?

The Earnings Per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY has increased by Negative YoY .